Pharmaceutical and chemical companies questioned on facilitating UK-EU trade

• Parliament TV: “Beyond tariffs: facilitating future UK-EU trade in manufactured goods”
• Call for evidence: “Beyond tariffs: facilitating future UK-EU trade in manufactured goods”
• Inquiry: “Beyond tariffs: facilitating future UK-EU trade in manufactured goods”EU Goods Sub-Committee

Witnesses

Monday 22 June 2020 at 10.30am , virtual meeting

the Committee will hear from:

• Dr Louise Gill, Head of Policy, Global Regulatory Affairs, GlaxoSmithKline
• Richard Ayton, Director of Government Affairs, Dow Chemical UK and Ireland

Areas of interest 

 Possible questions that may be asked by the Committee include:

• What regulatory provisions would you like to see in the UK-EU trade agreement?
• How important is the mutual recognition of good manufacturing practices / conformity assessments?
• What form should UK-EU cooperation on market surveillance take?
• How will new UK-EU customs procedures at the end of the transition period impact your businesses?
• Do you have any specific concerns?
• Are there any unilateral measures that the UK could take to reduce non-tariff barriers to UK-EU trade?

Further information

• About Committees: Select committees  
• Visiting Parliament: Watch committees